
### Copy number aberrations as markers for drug sensivitity/prognosis/diagnosis:

A total of __`r nrow(cna_data$cna_biomarker_segments)`__ unique, copy number aberration(s) in the tumor sample can be mapped to genomic biomarkers in the [database for clinical interpretations of variants in cancer, CIViC](https://civic.genome.wustl.edu/#/home), with a total of __`r nrow(cna_data$cna_biomarkers)`__ evidence items:
<br>

```{r cna_biomarkers, echo=F}

if(nrow(cna_data$cna_biomarkers) > 0){
  myOptions <- list(paging = T,pageLength=10, searching=T,caching=F)
  
  DT::datatable(cna_data$cna_biomarkers, options = myOptions, escape=F, extensions = "Responsive") %>%
  DT::formatStyle('EVIDENCE_LEVEL', backgroundColor = DT::styleEqual(c('A: Validated','B: Clinical evidence','C: Case study','D: Preclinical evidence','E: Indirect evidence'), c("#009E73","#56B4E9", "#0072B2","#E69F00", "#F0E442")))
}
```
